Mounjaro Treatment in Hyderabad — Doctor-Supervised Tirzepatide Therapy

Struggling with uncontrolled blood sugar or stubborn weight gain? Mounjaro (Tirzepatide) is the breakthrough weekly injection that targets both — and at Asian Diabetic Center, you get it under the supervision of a qualified endocrinologist, Dr. Shalini Patlolla, MD.

FDA-approved & CDSCO-cleared in India Personalised dosing protocol Endocrinologist supervision at every step Available at Madinaguda & KPHB clinics

Best Endocrinologist in Hyderabad | Dr. Shalini Patlolla

10,000+

Patients Treated

98%

Satisfaction Rate

10+

Years of Experience

Dr. Shalini Patlolla - Best Endocrinologist and Diabetologist in Hyderabad

About- Dr. Shalini Patlolla

(Regd No. 64787) Senior Consultant Endocrinologist & Diabetologist [MD, DM Endocrinology (SVIMS)]

Ex. Chief Consultant Endocrinologist & Diabetologist AIG Hospitals, Gachibowli, Hyderabad.

Dr. Shalini Patlolla – Leading Endocrinologist & Diabetologist in Hyderabad

Dr. Shalini Patlolla is one of the best Endocrinologists in Hyderabad, known for her patient-first approach to treating complex diabetes, thyroid, and hormonal disorders. She completed her DM in Endocrinology from Sri Venkateswara Institute of Medical Sciences (SVIMS), Tirupati – one of India’s top institutions for Endocrine training. She previously served as Chief Consultant Endocrinologist at AIG Hospitals, Gachibowli.

Why Choose Asian Diabetic Center for Mounjaro Treatment in Hyderabad?

Most clinics offering Mounjaro in Hyderabad are cosmetic centres or general wellness clinics. We’re different — Asian Diabetic Center is a dedicated endocrinology and diabetes practice, which means Mounjaro is prescribed where it belongs: under specialist care.

Here’s what makes us the preferred choice:

  • Specialist-led care: Dr. Shalini Patlolla, MD (Endocrinology), evaluates every patient personally — not a junior physician.
  • Complete metabolic workup before prescription: HbA1c, fasting insulin, lipid panel, kidney function, thyroid screening.
  • Structured dose titration: We follow Eli Lilly’s evidence-based escalation protocol (2.5 mg → 15 mg over months) to minimise side effects.
  • Side-effect management: Nausea, GI issues, and appetite changes are actively monitored and addressed.
  • Genuine Mounjaro only: Authentic Eli Lilly KwikPen procured through authorised channels — no grey-market or counterfeit risk.
  • Two convenient locations: Madinaguda and KPHB — both with on-site consultation, lab tie-ups, and follow-up scheduling.

What is Mounjaro (Tirzepatide)?

Mounjaro is the brand name for tirzepatide, a once-weekly subcutaneous injection developed by Eli Lilly. It’s the world’s first dual GIP and GLP-1 receptor agonist — meaning it activates two natural gut hormones simultaneously to control blood sugar and reduce body weight.

It was launched in India in August 2025 as the Mounjaro KwikPen, making authentic, regulated supply available locally for the first time.

Approved Uses:

  • Type 2 diabetes management (HbA1c control)
  • Chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions

How Mounjaro Works — The Dual-Hormone Advantage

Unlike Ozempic or Wegovy (which act on only GLP-1), Mounjaro works on two hormone pathways:

GLP-1 (Glucagon-Like Peptide-1)
  • Triggers insulin release when blood sugar rises
  • Slows stomach emptying, reducing post-meal glucose spikes
  • Signals fullness to the brain, lowering appetite
GIP (Glucose-Dependent Insulinotropic Polypeptide)
  • Boosts insulin secretion further
  • Improves how your body uses fat for energy
  • Works synergistically with GLP-1 for stronger metabolic effects

This dual action is why Mounjaro delivers superior HbA1c reduction (up to 2.4%) and weight loss (15–22%) compared to single-action GLP-1 drugs.

It was launched in India in August 2025 as the Mounjaro KwikPen, making authentic, regulated supply available locally for the first time.

Approved Uses:

  • Type 2 diabetes management (HbA1c control)
  • Chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions

Who Should Consider Mounjaro Treatment in Hyderabad?

You may be a candidate for Mounjaro if you have:

  • Type 2 diabetes that isn’t well-controlled on metformin or other oral medications
  • HbA1c above 7% despite lifestyle changes
  • Obesity (BMI ≥30) or overweight (BMI ≥27) with conditions like hypertension, PCOS, or sleep apnea
  • Insulin resistance or prediabetes with weight concerns
  • History of failed diet-and-exercise weight loss attempts

Mounjaro is NOT recommended if you have:

  • Type 1 diabetes
  • Personal or family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Severe gastroparesis or pancreatitis history
  • Pregnancy, planning pregnancy, or breastfeeding

A consultation with Dr. Shalini Patlolla determines whether Mounjaro is right for your specific case.

Mounjaro vs Ozempic vs Trulicity — Which Is Better?

FeatureMounjaro (Tirzepatide)Ozempic (Semaglutide)Trulicity (Dulaglutide)
MechanismDual GIP + GLP-1GLP-1 onlyGLP-1 only
HbA1c reduction

Up to 2.4%

Up to 1.8%Up to 1.6%
Weight loss15–22%12–15%8–10%
FrequencyOnce weeklyOnce weeklyOnce weekly
Available in IndiaYes (Aug 2025)LimitedYes

Verdict: For most Type 2 diabetes patients struggling with weight, Mounjaro currently offers the strongest outcomes. However, the right choice depends on your individual profile — which we determine during consultation.

Mounjaro Injection Price in Hyderabad

Mounjaro pricing in India is regulated, but final cost depends on your prescribed dose strength (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg). At Asian Diabetic Center, we offer:

  • Transparent pricing with no hidden fees
  • Genuine Eli Lilly KwikPen only — sourced through authorised pharmacy partners
  • Consultation + medication packages for predictable monthly cost
  • Lab investigations at partner-rate pricing

📞 Call us at +91 9133552279 for current Mounjaro injection price in Hyderabad and to verify availability.

Side Effects & How We Manage Them

Most side effects are mild and resolve as your body adapts. Common ones include:

Usually temporary:

  • Nausea (most common in first 4 weeks)
  • Diarrhoea or constipation
  • Decreased appetite
  • Mild abdominal discomfort
  • Injection-site redness

Our side-effect management approach:

  • Eat smaller, frequent meals
  • Avoid oily, fried, or very rich foods early in treatment
  • Hydrate adequately (2.5–3 L/day)
  • Take injection on the same day each week
  • Report persistent symptoms — we adjust dosing rather than discontinue

Seek immediate medical attention for: severe abdominal pain (possible pancreatitis), persistent vomiting, vision changes, or signs of allergic reaction.

CLINIC DETAILS & BOOKING

Thyroid Specialist Near Me — Areas Served from Our Madinaguda Clinic

H.No. 7-1/2, Above New Reliance Car Decors Sri Durga Colony, Madinaguda, Main Road, Hyderabad, Telangana 500049

Daytime Clinic (Madinaguda hours): Monday to Saturday, 12:00 PM – 3:00 PM Evening Clinic (KPHB hours): Monday to Saturday, 6:00 PM – 8:00 PM Phone: +91 9133552279

Both daytime and evening consultations are with Dr. Shalini Patlolla at the same clinic location. Choose the timing that works for your schedule.

Walk-In: Visit during consultation hours. Calling or messaging ahead reduces wait time. WhatsApp: Message +91 9133552279 with your name and preferred timing. Video Consultation: Available on HealthPlix for follow-ups and report reviews. → Book on HealthPlix

Frequently Asked Questions

Is Mounjaro available in Hyderabad?

Yes. Mounjaro KwikPen has been officially available in India since August 2025. At Asian Diabetic Center (Madinaguda & KPHB), we prescribe and supply authentic Mounjaro under endocrinologist supervision.

No. Mounjaro is a prescription-only medication and requires medical evaluation. Self-sourcing through unauthorised channels carries safety, authenticity, and legal risks.

Mounjaro is a long-term therapy. Stopping it usually causes blood sugar and weight to return. Maintenance strategies are discussed during follow-ups.


Tirzepatide is also approved for chronic weight management (branded as Zepbound globally). At Asian Diabetic Center, we evaluate eligibility based on BMI and metabolic profile.

Most patients notice blood sugar improvement within 2–4 weeks. Significant weight loss typically begins from week 8–12 as the dose increases.

Yes. Mounjaro is commonly combined with metformin and SGLT2 inhibitors. If you’re on insulin, the dose is usually reduced to prevent hypoglycaemia. Dr. Patlolla adjusts your regimen.

Take it as soon as you remember if within 4 days of the scheduled dose. If more than 4 days have passed, skip that dose and resume your normal schedule. Don’t double-dose.

Consult Dr. Shalini Patlolla – Trusted Diabetes & Endocrine Specialist in Hyderabad Today

B1ook your appointment today with Dr. Shalini Patlolla, Hyderabad’s top diabetes and endocrinology specialist, for expert diabetes management, thyroid care, PCOD treatment, and complete hormonal health solutions. Start your journey to better health and balanced living with personalized care from a trusted diabetes doctor in Hyderabad.

Scroll to Top